IP Verse

Improved Methods Of Genetically Modifying Animal Cells - EP3049515

The patent EP3049515 was granted to Wilson Wolf Manufacturing on Mar 13, 2019. The application was originally filed on Sep 23, 2014 under application number EP14845082A. The patent is currently recorded with a legal status of "Revoked".

EP3049515

WILSON WOLF MANUFACTURING
Application Number
EP14845082A
Filing Date
Sep 23, 2014
Status
Revoked
Feb 27, 2024
Grant Date
Mar 13, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EUROPEAN OPPOSITIONSDec 13, 2019MAIWALDADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO0009168
INTERNATIONAL-SEARCH-REPORTEP0725134
INTERNATIONAL-SEARCH-REPORTUS2005106717
INTERNATIONAL-SEARCH-REPORTUS2013102075
INTERNATIONAL-SEARCH-REPORTUS7799560
INTERNATIONAL-SEARCH-REPORTWO9907870
OPPOSITIONEP0725134
OPPOSITIONEP2471901
OPPOSITIONUS2005106717
OPPOSITIONUS2013102075
OPPOSITIONUS7799560
OPPOSITIONWO0009168
OPPOSITIONWO0056870
OPPOSITIONWO2015042595
OPPOSITIONWO9907870
SEARCHWO0009168

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- LAMERS et al., "Protocol for gene transduction and expansion of human T lympocytes for clinical immunogene therapy of cancer", Cancer Gene Therapy, (20020000), vol. 9, pages 613 - 623, XP003020145
OPPOSITION- COSTELLO et al., "GENE TRANSFER INTO STIMULATED AND UNSTIMULATED T LYMPHOCYTES BY HIV-1-DERIVED LENTIVIRAL VECTORS", Gene Therapy, (20000000), vol. 7, pages 596 - 604, XP001057677
OPPOSITION- VERA et al., "Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)", Journal of Immunotherapy, (20100000), vol. 33, no. 3, pages 305 - 315, XP055031297
OPPOSITION- JIANJIAN et al., "Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment", Journal of Immunotherapy, (20120000), vol. 35, no. 3, pages 283 - 292, XP008153078
OPPOSITION- KALOS et al., "T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia", Science Translational Medicine, (20110000), vol. 3, no. 95, page 95ra73, XP002667262
OPPOSITION- VERA et al., "Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes", Current Gene Therapy, (20090000), vol. 9, no. 5, pages 396 - 408, XP002683648
OPPOSITION- LAPTEVA et al., "Optimization Manufacture of Virus- and Tumor-Specific T Cells", Stem Cells International, (20110000), vol. 2011, pages 1 - 8, XP055031037
OPPOSITION- SOMERVILLE et al., "Bioreactors get personal", Oncoimmunology, (20120000), vol. 1, no. 8, pages 1435 - 1437, XP055337165
OPPOSITION- LIN et al., "Efficient lentiviral Transduction of Human Mesenchymal Stem Cells That Preserves Proliferation and Differentiation Capabilities", Stem Cells Translational Medicine, (20120000), vol. 1, pages 886 - 897, XP055662368
SEARCH- LAMERS C H J ET AL, "Protocol for gene transduction and expansion of human T lympocytes for clinical immunogene therapy of cancer", CANCER GENE THERAPY, APPLETON & LANGE, GB, (2002), vol. 9, doi:10.1038/SJ.CGT.7700477, ISSN 0929-1903, pages 613 - 623, XP003020145 [X] 1-3,5,6 * page 615 - page 618; figure 4 *
SEARCH- JUAN F. VERA ET AL, "Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)", JOURNAL OF IMMUNOTHERAPY, (201004), vol. 33, no. 3, doi:10.1097/CJI.0b013e3181c0c3cb, ISSN 1524-9557, pages 305 - 315, XP055031297 [Y] 4,7-14 * page 7 *
SEARCH- JIN JIANJIAN ET AL, "Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment", JOURNAL OF IMMUNOTHERAPY, LIPPINCOTT WILLIAMS & WILKINS, USA, (201204), vol. 35, no. 3, doi:10.1097/CJI.0B013E31824E801F, ISSN 1537-4513, pages 283 - 292, XP008153078 [Y] 4,7-14 * page 286 - page 287 *
SEARCH- KALOS MICHAEL ET AL, "T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia", 20110810, (20110810), vol. 3, no. 95, doi:10.1126/SCITRANSLMED.3002842, page 95ra73.1, XP002667262 [Y] 4,7-14 * page 9 - page 10; figure 1 *
SEARCH- NATALIA LAPTEVA ET AL, "Optimization Manufacture of Virus- and Tumor-Specific T Cells", STEM CELLS INTERNATIONAL, (2011), vol. 2011, doi:10.4061/2011/434392, ISSN 1687-966X, pages 1 - 8, XP055031037 [Y] 4,7-14 * table 1 *
SEARCH- ROBERT P.T. SOMERVILLE ET AL, "Bioreactors get personal", ONCOIMMUNOLOGY, (201211), vol. 1, no. 8, doi:10.4161/onci.21206, pages 1435 - 1437, XP055337165 [Y] 4,7-14 * page 1436; figure 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents